The global women's health market was valued at USD 35.02 billion in 2019 and is expected to reach USD 41.05 billion by 2027, growing at a CAGR of 3.2% during the forecast period. In 2019, North America led the market, holding a dominant share of 51.4%.
The women’s health market encompasses a wide range of products, services, and technologies focused on addressing health conditions unique to women, including reproductive health, menopause, osteoporosis, and gynecological disorders. This market is witnessing steady growth due to increasing awareness about women-specific health issues, rising healthcare expenditures, and advancements in diagnostics and treatment options. Factors such as the growing prevalence of chronic conditions among women, aging female populations, and favorable government initiatives are also contributing to market expansion. Moreover, ongoing research and innovation in areas such as fertility treatments, hormonal therapies, and digital health solutions tailored for women are further propelling the market forward.
Continue reading for more details:
https://www.fortunebusinessinsights.com/industry-reports/women-s-health-market-101847
Women’s Health Market – Snapshot & Highlights
Market Size & Forecast:
2019 Market Size: USD 35.02 billion
2027 Forecast Market Size: USD 41.05 billion
CAGR:2% (2020–2027)
Market Share:
Regional Leadership: North America accounted for 51.4% of the global women’s health market in 2019, driven by high adoption of women’s health products in the U.S. and Canada, substantial healthcare spending, and the presence of leading market players.
By Application: The contraceptives segment led in 2019, supported by rising unintended pregnancy cases and continuous product launches. Osteoporosis ranked second, fueled by higher disease prevalence among women and supportive reimbursement policies.
Key Country Highlights:
United States: Market leadership supported by high breast cancer prevalence (estimated 276,480 new invasive cases in 2020), significant healthcare expenditure on women’s health, and strong pharmaceutical infrastructure.
Canada: Growth driven by targeted initiatives for women-centric diseases and expanding public awareness programs.
Germany & United Kingdom (Europe): Second-largest regional market, supported by heightened disease awareness, robust healthcare systems, and government-led health campaigns.
Middle East & Africa: Currently a smaller market due to limited product access, but expansion is underway through public–private partnerships and health awareness initiatives.
Market Segmentation
By Product Type:
Devices (IUDs, vaginal rings, breast pumps)
Pharmaceuticals (HRT, contraceptives, fertility drugs)
Diagnostics (fertility tests, cancer screening tools)
By Application:
Reproductive health and contraception
Menopause management
Osteoporosis treatment
Cancer care (breast, ovarian, cervical)
Maternal and prenatal health
By End User:
Hospitals
Specialty clinics
Diagnostic centers
Homecare settings
Online pharmacies
By Distribution Channel:
Hospital pharmacies
Retail pharmacies
E-commerce platforms
By Age Group:
Adolescents
Adults
Middle-aged women
Elderly women
List of Key Companies Profiled in the Women’s Health Market Report:
Agile Therapeutics (New Jersey, USA)
LUPIN (Mumbai, India)
Merck & Co., Inc. (New Jersey, United States)
Amgen Inc. (California, United States)
Bayer AG (Leverkusen, Germany)
AstraZeneca (Cambridge, UK)
Eli Lilly and Company (Indiana, United States)
Novartis AG (Basel, Switzerland)
Pfizer Inc. (New York, United States)
Market Growth
The Women’s Health Market is experiencing strong growth fueled by increased awareness of women-specific conditions and rising healthcare spending.
Growing demand for reproductive health services, fertility treatments, and maternal care is driving expansion of the Women’s Health Market.
Advances in diagnostics, pharmaceuticals, and telehealth platforms are accelerating innovation across the Women’s Health Market.
Supportive government initiatives and public health programs targeting women’s wellness are boosting momentum in the Women’s Health Market.
Increasing investments by private players and partnerships focused on holistic women's care are strengthening the Women’s Health Market.
Restraining Factors
Cultural stigmas and lack of awareness in certain regions can limit demand in the Women’s Health Market.
Regulatory hurdles and long approval timelines for women’s medical products may restrain expansion of the Women’s Health Market.
High cost of specialized treatments and diagnostics can be a barrier within the Women’s Health Market.
Inadequate insurance coverage and limited reimbursement policies restrict growth in emerging markets of the Women’s Health Market.
Shortage of trained specialists and poor patient adherence to long-term therapies pose challenges for the Women’s Health Market.
Regional Analysis
North America: leads the Women’s Health Market with advanced infrastructure, extensive R&D, and high adoption of women-focused technologies.
Europe: strong presence in the Women’s Health Market, supported by national health programs, preventive screening, and contraceptive coverage.
Asia Pacific: rapidly growing Women’s Health Market driven by expanding healthcare access, urbanization, and government investments in maternal services.
Latin America: gradual growth in the Women’s Health Market, as awareness campaigns and improved facility access reach more women.
Middle East & Africa: emerging Women’s Health Market opportunities fueled by increasing healthcare initiatives, female education, and international partnerships.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045, Maharashtra, India.
Phone: U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com